- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06812897
Sallie Life U Feasibility Study (SLU)
February 10, 2025 updated by: Life University
Assessing the Feasibility of a Patient-Driven Chiropractic Patient Portal (SallieTM Life U) for Research Purposes
This feasibility trial explored the usability of the patient-driven chiropractic patient portal, Sallie™ Life U. The study aimed to recruit 30 participants to track their daily symptoms, triggers, and habits over 30 days while completing three questionnaires about their experience with the portal.
The first questionnaire was administered after participants created their accounts, the second at the midpoint of tracking (day 15), and the third upon completing the tracking period (day 30).
All participation in the study was conducted remotely using the participants' personal devices.
Study Overview
Study Type
Observational
Enrollment (Actual)
28
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Marietta, Georgia, United States, 30060
- Dr. Sid E Williams Center for Chiropractic Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
No specific population
Description
Inclusion Criteria:
- Have daily access to technology (smartphone, tablet, or computer)
- Currently receiving chiropractic care (for the purposes of this feasibility study, this requires at least one chiropractic adjustment each month)
Exclusion Criteria:
- Given software restrictions, participants must also be able to read and write in English and not be visually impaired.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy
Healthy subjects
|
Testing of Sallie (TM) Life U platform
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Recruitment
Time Frame: 30 days
|
Average # of participants to create a SallieTM Life U account per month
|
30 days
|
|
Participant Adherence - Weekly
Time Frame: 30 days
|
% of participants with daily data input throughout the week
|
30 days
|
|
Participant Adherence - Monthly
Time Frame: 30 days
|
% of participants with total number of daily data input throughout the month.
|
30 days
|
|
Participant Retention
Time Frame: 30 days
|
% of participants completing all questionnaires
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Personalized Tracking Metrics (PTMs)
Time Frame: 30 days
|
Self-generated habits or personal goals that participants create and track in their portals
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Stephanie Sullivan, DC, PhD, Dr. Sid E Williams Center for Chiropractic Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Actual)
January 30, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
January 31, 2025
First Submitted That Met QC Criteria
January 31, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 10, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- I-0031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.